From: Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America
Diabetes type | Description |
---|---|
Type 1 diabetes mellitus (T1DM) | β-Cell destruction, usually leading to absolute insulin deficiency |
Type 2 diabetes mellitus (T2DM) | Varying degrees of insulin resistance and long-term insulin deficiency |
Gestational diabetes mellitus (GDM) | Pregnant women who have never had diabetes mellitus but who experience high blood glucose levels during pregnancy |
Maturity-onset diabetes of the young (MODY) | Rare form of diabetes that is distinct from both type 1 and type 2 diabetes and strongly runs in families. It is caused by a mutation in a single gene. If a parent has this gene mutation, any child has a 50% chance of inheriting it |
Latent autoimmune diabetes of the adult (LADA) | Disorder in which, despite the presence of islet antibodies at diagnosis of diabetes, the progression of autoimmune β-cell failure is slow |
Diseases of exocrine pancreas | Includes pancreatitis, trauma, infection, neoplasia, cystic fibrosis, hemochromatosis, pancreatectomy, and others |
Endocrinopathies | Includes acromegaly, Cushing’s syndrome, glucagonoma, hyperthyroidism, somatostatinoma, and others |
Drug- or chemical-induced diabetes | Includes some immunotherapy, exogenous steroids, antipsychotics medication, statins, and others |
Infections | Congenital rubella and other viruses have been implicated |
Uncommon forms of immune-mediated diabetes | Rare cases of diabetes associated with new checkpoint inhibitor therapies |
Stiff-man syndrome | An autoimmune disorder of the central nervous system, usually with high titers of glutamic acid decarboxylase [GAD] autoantibodies |